Disc Medicine Inc. (IRON)
NASDAQ: IRON
· Real-Time Price · USD
67.78
1.92 (2.92%)
At close: Oct 03, 2025, 3:59 PM
68.58
1.18%
After-hours: Oct 03, 2025, 04:38 PM EDT
2.92% (1D)
| Bid | 57.75 |
| Market Cap | 2.36B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -145.39M |
| EPS (ttm) | -4.53 |
| PE Ratio (ttm) | -14.96 |
| Forward PE | -9.99 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 69 |
| Volume | 262,706 |
| Avg. Volume (20D) | 381,129.4 |
| Open | 65.98 |
| Previous Close | 65.86 |
| Day's Range | 65.35 - 67.92 |
| 52-Week Range | 30.82 - 68.79 |
| Beta | 2.50 |
| Ex-Dividend Date | n/a |
About IRON
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IRON
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IRON stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts11 months ago
+11.21%
Disk Medicine shares are trading higher. HC Wainwr...
Unlock content with
Pro Subscription
11 months ago
+23.59%
Disc Medicine shares are trading higher after the company announced the end of its Phase 2 Bitopertin In Erythropoietic Protoporphyria meeting with the FDA. The company is aligned with the FDA across all proposed study parameters and has a clear development path to registration.
